B+
Bull case
25%
Probability
Target price
$38.00
+23.1% vs current
PNTG
Pennant GroupBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$33.00
+6.9% vs current
B-
Bear case
25%
Probability
Target price
$25.50
-17.4% vs current
AI sentiment snapshot
Latest data as of 2026-04-15
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+53.8
Score
AI commentary
Deterministic priors lean positive, but the evidence still supports a monitoring-style memo rather than an aggressive long. Evidence quality is only moderate, catalyst density is low, and the forward thesis is still heavily dependent on management executing an integration-heavy 2026 plan already framed in the February 2026 8-K package. [#8-K-2026-02-25]
RankAlpha Sentiment Codex - 2026-04-15
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-15catalystFirst 2026 quarter check against the February guideHigh impact
The key near-term readout is whether the first 2026 quarter supports Pennant's February 25, 2026 guide of $1.1336-$1.1718 billion revenue, $1.26-$1.36 adjusted EPS, and $88.5-$94.1 million adjusted EBITDA. Management said that guide already includes UnitedHealth transition-services costs, reimbursement adjustments, contribution from former UnitedHealth/Amedisys assets, and no unannounced acquisitions, so an early 2026 quarter miss would matter. [#8-K-2026-02-25]
2026-09-30catalystIntegration and local execution across the expanded care footprintHigh impact
The medium-term bull case is continued clean integration of acquired operations while preserving same-store momentum. In the February 25, 2026 earnings release, home health admissions rose 44.1% in 2025, hospice average daily census rose 28.6%, senior-living fourth-quarter occupancy reached 80.6%, and management said 2026 will focus on integrating new operations and instilling operational excellence. The 10-K also shows a scaled footprint of 172 home health and hospice agencies and 63 senior living communities across 16 states, raising both the opportunity and the execution burden. [#8-K-2026-02-25] [#10-K-2026-02-26]
2026-12-31eventAcquisition optionality remains outside formal guidanceHigh impact
Pennant's guidance excludes unannounced acquisitions, leaving event-driven upside if management adds tuck-ins. That option is supported by 2025 operating cash flow of $48.3 million, a $250 million revolving credit facility with maturity in 2029, and a $100 million incremental term loan added in November 2025, although any deal must still clear integration capacity and reimbursement risk. [#8-K-2026-02-25] [#10-K-2026-02-26]
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-15 • Updated nightlySource: Internal modelMethodology